BioMarin Pharma (BMRN) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	707.35M
Short-term investments	327.5M
Accounts receivable, net (allowance for doubtful accounts: $969 and $63, respectively)	215.89M
Inventory	347.42M
Other current assets	68.41M
Total current assets	1.67B
Investment in BioMarin/Genzyme LLC
Long-term investments	362.96M
Property, plant and equipment, net	729.84M
Intangible assets, net	561.39M
Goodwill	197.04M
Long-term deferred tax assets	288.01M
Other assets	36.44M
Total assets	3.84B
Accounts payable and accrued liabilities	306.13M
Total current liabilities	377.34M
Convertible debt	653.18M
Other long-term liabilities	43.27M
Total liabilities	1.2B
Common stock, $0.001 par value: 250,000,000 shares authorized at June 30, 2011 and December 31, 2010 : 111,564,800 and 110,634,465 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively	173K
Additional paid-in capital	4.23B
Company common stock held by Nonqualified Deferred Compensation Plan
Accumulated other comprehensive income (loss)	2.16M
Accumulated deficit	-1.57B
Total stockholders' equity	2.65B
Total liabilities and stockholders' equity	3.84B

Entities mentioned with BMRN

View All Entities